TY - JOUR
T1 - Structural basis of differences in isoform-specific gating and lidocaine block between cardiac and skeletal muscle sodium channels
AU - Li, Ronald A.
AU - Ennis, Irene L.
AU - Tomaselli, Gordon F.
AU - Marbán, Eduardo
PY - 2002
Y1 - 2002
N2 - Voltage-gated Na+ channels underlie rapid conduction in heart and skeletal muscle. Cardiac sodium channels open and close over more negative potentials than do skeletal muscle sodium channels; heart channels are also more sensitive to lidocaine block. The structural basis of these differences is poody understood. We mutated nine isoform-specific υ1 (rat skeletal muscle) channel residues in domain IV to those at equivalent locations in hH1 (human cardiac) channels. Channel constructs were expressed in tsA-201 cells and screened for changes in gating and lidocaine sensitivity. Only L1373E, located in the linker between the S1 and S2 transmembrane segments, shifted activation gating and use-dependent block by lidocaine toward that seen in hH1. The converse mutation, hH1-E1555L, shifted the phenotype of hill to resemble that of υ1. Therefore, we identified a previously unsuspected glutamate-to-leucine isoform-specific variant site (i.e., 1555 in hH1 and 1373 in υ1) that significantly influences gating and drug block in sodium channels. The identification of the residue at this position plays a major role in shaping the responses of sodium channels to voltage and to lidocaine, helping to rationalize the distinctive behavior of cardiac sodium channels.
AB - Voltage-gated Na+ channels underlie rapid conduction in heart and skeletal muscle. Cardiac sodium channels open and close over more negative potentials than do skeletal muscle sodium channels; heart channels are also more sensitive to lidocaine block. The structural basis of these differences is poody understood. We mutated nine isoform-specific υ1 (rat skeletal muscle) channel residues in domain IV to those at equivalent locations in hH1 (human cardiac) channels. Channel constructs were expressed in tsA-201 cells and screened for changes in gating and lidocaine sensitivity. Only L1373E, located in the linker between the S1 and S2 transmembrane segments, shifted activation gating and use-dependent block by lidocaine toward that seen in hH1. The converse mutation, hH1-E1555L, shifted the phenotype of hill to resemble that of υ1. Therefore, we identified a previously unsuspected glutamate-to-leucine isoform-specific variant site (i.e., 1555 in hH1 and 1373 in υ1) that significantly influences gating and drug block in sodium channels. The identification of the residue at this position plays a major role in shaping the responses of sodium channels to voltage and to lidocaine, helping to rationalize the distinctive behavior of cardiac sodium channels.
UR - http://www.scopus.com/inward/record.url?scp=0036144123&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036144123&partnerID=8YFLogxK
U2 - 10.1124/mol.61.1.136
DO - 10.1124/mol.61.1.136
M3 - Article
C2 - 11752214
AN - SCOPUS:0036144123
SN - 0026-895X
VL - 61
SP - 136
EP - 141
JO - Molecular Pharmacology
JF - Molecular Pharmacology
IS - 1
ER -